Search

Your search keyword '"torsade de pointes"' showing total 1,314 results

Search Constraints

Start Over You searched for: Descriptor "torsade de pointes" Remove constraint Descriptor: "torsade de pointes"
1,314 results on '"torsade de pointes"'

Search Results

1. Intraoperative QTc interval interpretation: Effects of anaesthesia, ECG, correction formulae, sex, and current limits: A Prospective Observational Study.

2. Clinical presentation and genetic characterization of early‐onset atrial fibrillation in patients affected by long QT syndrome: A single‐center experience.

3. Roles of Atrial Arrhythmias in Triggering Torsade de Pointes in Patients With Acquired Long QT Syndrome.

4. Assessment of QTc-interval Prolonging Medication Utilization and Associated Potential Drug-Drug Interactions in Hospitalized Cardiac Patients: A CrossSectional Study in Cardiology.

5. Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta‐analysis.

6. QTc Interval Prolongation as an Adverse Event of Azole Antifungal Drugs: Case Report and Literature Review.

7. In Silico Human Cardiomyocyte Action Potential Modeling: Exploring Ion Channel Input Combinations.

8. Case report: Phosphoinositide 3- kinase inhibitor with fulvestrant in a patient with ER+/HER2- metastatic breast carcinoma induced fatal arrhythmias: a preventable event?

9. Safety of dofetilide in stable patients and investigating traits of susceptibility to torsade de pointes

10. Analysis of cardiohemodynamic and electrophysiological effects of morphine along with its toxicokinetic profile using the halothane-anesthetized dogs.

11. Evaluation of cardiac pro-arrhythmic risks using the artificial neural network with ToR-ORd in silico model output.

12. The Best ECG Lead for Predicting the Risk of Drug-Induced Torsade De Pointes Using Corrected QT Interval: A Comparative Prognostic Study

13. Recurrent ventricular arrhythmias and heart failure induced by osimertinib- a case report

14. Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients

15. 药源性 QT 间期 / QTc 延长和尖端扭转型室性 心动过速的风险及预警措施的研究进展.

16. Takotsubo Cardiomyopathy Presenting with QT Prolongation and Torsade de Pointes in a Patient with Coronavirus Disease 2019.

17. «Torsade de pointes» en paciente con uso de abiraterona.

18. Evaluation of cardiac pro-arrhythmic risks using the artificial neural network with ToR–ORd in silico model output

19. QTc Interval Prolongation as an Adverse Event of Azole Antifungal Drugs: Case Report and Literature Review

20. Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.

21. Prolactin Inhibition to Treat Postpartum Arrhythmic Storm

22. Association of Torsade de Pointes and QT Prolongation With Antifungal Triazoles: Analysis Using a Pharmacovigilance Database.

23. Machine learning approach to evaluate TdP risk of drugs using cardiac electrophysiological model including inter-individual variability.

25. Worldwide Survey of COVID-19–Associated Arrhythmias

26. High-rate pacing suppresses Torsade de Pointes arrhythmias and reduces spatial dispersion of repolarization in the chronic AV-block dog model

27. Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database

28. Machine learning approach to evaluate TdP risk of drugs using cardiac electrophysiological model including inter-individual variability

29. Directed graph mapping shows rotors maintain non-terminating and focal sources maintain self-terminating Torsade de Pointes in canine mode.

30. Dostarlimab, an anti‐programmed death‐1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration‐QT analysis.

31. Prolonged QT Interval in Cirrhosis: Twisting Time?

32. Role of cardiac α1-adrenoreceptors for the torsadogenic action of IKr blocker nifekalant in the anesthetized atrioventricular block rabbit

33. Contribution of cytokine-mediated prolongation of QTc interval to the multi-hit theory of Torsade de Pointes.

34. Linezolid and the risk of QT interval prolongation: A pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System.

35. Directed graph mapping shows rotors maintain non-terminating and focal sources maintain self-terminating Torsade de Pointes in canine model

36. Bedaquiline Correlation to QT Interval Prolongation in DR-TB Patients

37. Occurrence of Torsade de Pointes prior to complete lead connection during pacemaker implantation

38. Cancer treatment and drug-induced QT interval prolongation: A review

39. Takotsubo syndrome and its linkage to neuroendocrinological disorders: a case report.

40. Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study.

41. Takotsubo Syndrome and Sudden Cardiac Death.

42. The TANGO2 disease and the therapeutic challenge of acute arrhythmia management: a case report.

43. Characterization of pathological remodeling in the chronic atrioventricular block cynomolgus monkey heart.

44. Antiviral and anti-inflammatory drugs to combat COVID-19: Effects on cardiac ion channels and risk of ventricular arrhythmias

45. Open-access database of literature derived drug-related Torsade de Pointes cases

46. A case report of sudden cardiac arrest and torsade de pointes induced by the second-generation tyrosine kinase inhibitor dasatinib combined with fluconazole

47. Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors.

48. Validation of Risk-Stratification Method for the Chronic Atrioventricular Block Cynomolgus Monkey Model and Its Mechanistic Interpretation Using 6 Drugs With Pharmacologically Distinct Profile.

49. Prolonged QT Interval in Cirrhosis: Twisting Time?

50. The Role of Hypomagnesemia in Cardiac Arrhythmias: A Clinical Perspective.

Catalog

Books, media, physical & digital resources